Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
阿卡宁B滴丸随机双盲、安慰剂对照、单次给药、剂量递增的健康人体耐受性、药代动力学Ia期临床试验
[Translation] A phase Ia randomized, double-blind, placebo-controlled, single-dose, dose-escalation clinical trial of tolerability and pharmacokinetics of Akanin B drops in healthy humans
观察健康受试者对单次给药的阿卡宁B滴丸的安全性和耐受性,并对单次给药的药代动力学进行初步探索,为多次连续给药的耐受性试验、药代动力学试验及II期临床试验给药方案提供安全的剂量范围及参考依据。
[Translation] To observe the safety and tolerability of a single dose of Akanin B pills in healthy subjects, and to conduct a preliminary exploration of the pharmacokinetics of a single dose, so as to provide a safe dosage range and reference basis for tolerance tests, pharmacokinetic tests and dosing regimens of phase II clinical trials of multiple continuous doses.
100 Clinical Results associated with Beijing Jinbencao Chinese Medicine Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Jinbencao Chinese Medicine Technology Development Co., Ltd.
100 Deals associated with Beijing Jinbencao Chinese Medicine Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Jinbencao Chinese Medicine Technology Development Co., Ltd.